FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Divalproex Sodium Delayed-Release Tablets Recall

Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Aug 3, 2022
Recall ID
D-1291-2022
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Divalproex Sodium Delayed-Release Tablets starting Jun 27, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1291-2022 on Aug 3, 2022. Reason: Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.

Product description

Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.

Lot numbers, UPCs & expiration codes

Lot: HAC1312A, EXP. 05/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1291-2022
Classification
Class II
Status
Terminated
Recall initiated
Jun 27, 2022
FDA report date
Aug 3, 2022
Quantity
9552 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-1291-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
90495
Address
2 Independence Way
Code information
Lot: HAC1312A, EXP. 05/2024
Postal code
08540-6620
Report date
Aug 3, 2022
Product type
Drugs
Recall number
D-1291-2022
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
9552 bottles
Termination date
May 31, 2023
Reason for recall
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 27, 2022
Initial firm notification
Letter
Center classification date
Jul 26, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1291-2022, published Aug 3, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls